Knost JA - Search Results

1

Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer.

Saif MW, Knost JA, Chiorean EG, Kambhampati SR, Yu D, Pytowski B, Qin A, Kauh JS, O'Neil BH. Saif MW, et al. Among authors: knost ja. Cancer Chemother Pharmacol. 2016 Oct;78(4):815-24. doi: 10.1007/s00280-016-3134-3. Epub 2016 Aug 26. Cancer Chemother Pharmacol. 2016. PMID: 27566701 Clinical Trial.

2

A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer.

Lin EH, Lenz HJ, Saleh MN, Mackenzie MJ, Knost JA, Pathiraja K, Langdon RB, Yao SL, Lu BD. Lin EH, et al. Among authors: knost ja. Cancer Med. 2014 Aug;3(4):988-97. doi: 10.1002/cam4.263. Epub 2014 Jun 6. Cancer Med. 2014. PMID: 24905030 Free PMC article. Clinical Trial.

3

A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma.

Pitot HC, Knost JA, Mahoney MR, Kugler J, Krook JE, Hatfield AK, Sargent DJ, Goldberg RM. Pitot HC, et al. Among authors: knost ja. Cancer. 2000 Oct 15;89(8):1699-705. Cancer. 2000. PMID: 11042563 Clinical Trial.

4

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer.

Parikh AR, Lee FC, Yau L, Koh H, Knost J, Mitchell EP, Bosanac I, Choong N, Scappaticci F, Mancao C, Lenz HJ. Parikh AR, et al. Clin Cancer Res. 2019 May 15;25(10):2988-2995. doi: 10.1158/1078-0432.CCR-18-1221. Epub 2018 Sep 17. Clin Cancer Res. 2019. PMID: 30224341 Free PMC article. Clinical Trial.

5

A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia.

Nimeiri HS, Oza AM, Morgan RJ, Huo D, Elit L, Knost JA, Wade JL 3rd, Agamah E, Vokes EE, Fleming GF. Nimeiri HS, et al. Among authors: knost ja. Gynecol Oncol. 2010 Apr;117(1):37-40. doi: 10.1016/j.ygyno.2010.01.013. Epub 2010 Feb 1. Gynecol Oncol. 2010. PMID: 20117828 Free PMC article. Clinical Trial.

6

Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer.

Mani S, Kugler JW, Knost JA, Sciortino DF, Gibbons J, Garcia JC, Ansari RH, Schilsky RL, Vokes EE. Mani S, et al. Among authors: knost ja. Invest New Drugs. 1998-1999;16(3):275-8. doi: 10.1023/a:1006100116229. Invest New Drugs. 1998. PMID: 10360609 Clinical Trial.

7

Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.

Thorpe LM, Schrock AB, Erlich RL, Miller VA, Knost J, Le-Lindqwister N, Jujjavarapu S, Ali SM, Liu JJ. Thorpe LM, et al. Head Neck. 2017 Mar;39(3):E40-E44. doi: 10.1002/hed.24634. Epub 2016 Dec 22. Head Neck. 2017. PMID: 28006087 Review.

8

Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.

Alberts SR, Al-Khatib H, Mahoney MR, Burgart L, Cera PJ, Flynn PJ, Finch TR, Levitt R, Windschitl HE, Knost JA, Tschetter LK. Alberts SR, et al. Among authors: knost ja. Cancer. 2005 Jan 1;103(1):111-8. doi: 10.1002/cncr.20753. Cancer. 2005. PMID: 15558814 Free article. Clinical Trial.

9

Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium.

Sharma MR, Wroblewski K, Polite BN, Knost JA, Wallace JA, Modi S, Sleckman BG, Taber D, Vokes EE, Stadler WM, Kindler HL. Sharma MR, et al. Among authors: knost ja. Invest New Drugs. 2012 Jun;30(3):1211-5. doi: 10.1007/s10637-011-9681-x. Epub 2011 May 7. Invest New Drugs. 2012. PMID: 21552992 Free PMC article. Clinical Trial.

10

A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer.

Weitz JJ, Marschke RF Jr, Sloan JA, Grill JP, Jett JR, Knost JA, Hatfield AK, Zenk DW, Bate WW, Schaefer PL. Weitz JJ, et al. Among authors: knost ja. Lung Cancer. 2000 May;28(2):157-62. doi: 10.1016/s0169-5002(99)00128-2. Lung Cancer. 2000. PMID: 10717333 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters